Marc Cartellieri

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells

Christopher C. Kloss, Maud Condomines, Marc Cartellieri et al. · Nature Biotechnology · 2012 · 845 citations · Full text

Combinatorial Antigen Recognition, Cancer Immunosurveillance, T Cells +10

Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts

Marc Cartellieri, Anja Feldmann, Stefanie Koristka et al. · Blood Cancer Journal · 2016 · 243 citations · Full text

DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy

Katrin Töpfer, Marc Cartellieri, Susanne Michen et al. · The Journal of Immunology · 2015 · 241 citations

Proof of concept for a rapidly switchable universal CAR-T platform with UniCAR-T-CD123 in relapsed/refractory AML

Martin Wermke, Sabrina Kraus, Armin Ehninger et al. · Blood · 2021 · 160 citations · Full text

Relapsed/refractory Aml, Automotive Electronics, Engineering +1

Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”

Anja Feldmann, Claudia Arndt, Ralf Bergmann et al. · Oncotarget · 2017 · 119 citations · Full text